Newstral
Article
The Toledo Blade on 2015-12-16 09:14
AstraZeneca buys respiratory drug business
Related news
- AstraZeneca acquires Japanese firm's respiratory drug business for $575Mbizjournals.com
- Valeant Strikes Psoriasis-Drug Pact With AstraZenecawsj.com
- AstraZeneca buys most of Acerta for $4-billion to add cancer drugThe Globe and Mail
- MJapanese firm buys business news site Quartzmoney.cnn.com
- South Africa buys AstraZeneca vaccine...Shropshire Star
- Vaccine developer AstraZeneca buys US...Shropshire Star
- FAstraZeneca cancer drug breakthroughft.com
- $1.5B deal: AstraZeneca sells U.S. rights to respiratory medicinebizjournals.com
- Sold! Axel Springer Bets Big on Digital, Buys Business Insider.VOX recode
- Mallinckrodt buys respiratory drug maker for $2.3 billionbizjournals.com
- FAstraZeneca heart drug suffers failureft.com
- AstraZeneca buying drug developer in ...Shropshire Star
- AstraZeneca buys US biotech firm CinCortimesofmalta.com
- FAxel Springer buys Business Insiderft.com
- Coronavirus outbreak: Europe secures 400 million doses of Oxford vaccine from drug maker AstraZenecaSouth China Morning Post
- Merck and AstraZeneca to start COVID-19 drug trials in JapanThe Japan Times
- AstraZeneca seeks Japan's first approval for hereditary cancer drug in relapsed sufferersThe Japan Times